Determinants of hospital mortality after repeat mitral valve surgery for rheumatic mitral valve disease

Basit Öğe Kaydı
dc.authorid0000-0003-2543-2494en_US
dc.authorid0000-0001-5427-550Xen_US
dc.authorid0000-0002-4082-283Xen_US
dc.authorid0000-0001-7469-8059en_US
dc.authorid0000-0001-7953-1573en_US
dc.contributor.authorAlbeyoğlu, Şebnem
dc.contributor.authorSargın, Murat
dc.contributor.authorÇakmak, Mahmut
dc.contributor.authorGöksel, Onur
dc.contributor.authorBayserke, Olgar
dc.contributor.authorÇınar, B.
dc.contributor.authorEren, Ergin Emin
dc.date.accessioned2024-07-12T21:11:40Z
dc.date.available2024-07-12T21:11:40Z
dc.date.issued2006en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractObjective: The aim of this study is to detect the risk factors for hospital mortality in patients who underwent reoperative mitral valve replacement. Methods: Rheumatic mitral valve patients who underwent primary mitral valve replacement (386 cases) and repeat mitral valve replacement (94 cases) were analysed retrospectively. The incremental effects of the reoperative procedure on hospital mortality were studied by comparing primary and reoperative procedures and analyzing a series of possible predisposing factors. Results: Operative mortality for repeat procedures was found significantly higher than the first operations (respectively 12.8% versus 4.3%, p=0.022). Risc factors affecting the hospital mortality in reoperation group were determined as advanced age, diameter of left atrium, prolonged bypass time and development of postoperative low output state. The indication for surgery also had a significant role in patients' outcome. Mortality found significantly higher in cases operated due to endocarditis or mitral mechanical valve thrombosis compared to other reoperation groups. Conclusion: Patients over age of 70 years, with a left atrial diameter over 60 mm, reoperated due to endocarditis and mechanical valve thrombosis, should be reevaluated for risk assessment while giving the decision of optimal operation timing. Especially patients with left ventricular hypertrophy and decreased myocardial reservoirs, efficient myocardial protection during the operation had an important role.en_US
dc.identifier.citationAlbeyoglu, S. C., Filizcan, U., Sargin, M., Cakmak, M., Goksel, O., Bayserke, O., Cinar, B. ve Eren, E. (2006). Determinants of hospital mortality after repeat mitral valve surgery for rheumatic mitral valve disease. The Thoracic and cardiovascular surgeon, 54(4), 244–249.en_US
dc.identifier.endpage249en_US
dc.identifier.issn0022-5223
dc.identifier.issn1097-685X
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage244en_US
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/16755445/
dc.identifier.urihttps://hdl.handle.net/20.500.12415/4390
dc.identifier.volume54en_US
dc.institutionauthorFilizcan, Uğur
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofThe Journal of Thoracic and Cardiovascular Surgeryen_US
dc.relation.isversionof10.1055/s-2006-923946en_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsCC0 1.0 Universal*
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.snmzKY03559
dc.titleDeterminants of hospital mortality after repeat mitral valve surgery for rheumatic mitral valve diseaseen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu